Lise Sofie Haug Nissen-Meyer

  • Consultant, head of section; MD, PhD
  • +47 22117828 / 48284525
 

Publications 2024

Haugen M, Magnussen K, Aarsland TE, Nissen-Meyer LSH, Strand TA (2024)
The effect of donation frequency on donor health in blood donors donating plasma by plasmapheresis: study protocol for a randomized controlled trial
Trials, 25 (1), 175
DOI 10.1186/s13063-024-08035-7, PubMed 38468338

Hetland G, Fagerhol MK, Mirlashari MR, Nissen-Meyer LSH, Croci S, Lonati PA, Bonacini M, Salvarani C, Marvisi C, Bodio C, Muratore F, Borghi MO, Meroni PL (2024)
Elevated NET, Calprotectin, and Neopterin Levels Discriminate between Disease Activity in COVID-19, as Evidenced by Need for Hospitalization among Patients in Northern Italy
Biomedicines, 12 (4)
DOI 10.3390/biomedicines12040766, PubMed 38672123

Nguyen NT, Titze TL, Nissen-Meyer LSH (2024)
Evaluation of transfusion reactions in patients following transfusion of blood components containing antibodies to HLA class I - An attempt to prevent TRALI in patients
Transfus Apher Sci, 63 (4), 103970
DOI 10.1016/j.transci.2024.103970, PubMed 38964256

Publications 2023

Fagerhol MK, Schultz NH, Mirlashari MR, Wiedmann MKH, Nissen-Meyer LSH, Søraas AVL, Hetland G (2023)
DNase analysed by a novel competitive assay in patients with complications after ChAdOx1 nCoV-19 vaccination and in normal unvaccinated blood donors
Scand J Immunol, 98 (1), e13274
DOI 10.1111/sji.13274, PubMed 37676118

Johnsen KMN, Magnussen K, Erstad C, Bhatti SN, Nissen-Meyer LSH (2023)
Safe Blood Donation from Donors Using Antihypertensive Medication. A Multi-Center Retrospective Quality Study from South-East Norway
J Blood Med, 14, 337-343
DOI 10.2147/JBM.S390609, PubMed 37163174

Mahmood F, Nissen-Meyer LSH, Hetland G, Nentwich I (2023)
Assessing IgE sensitization profiles to birch and timothy grass pollen allergens in birch pollen allergic blood donors using an oligoplex specific IgE assay
Scand J Clin Lab Invest, 83 (7), 444-447
DOI 10.1080/00365513.2023.2255972, PubMed 37737679

Meyer S, Blaas I, Bollineni RC, Delic-Sarac M, Tran TT, Knetter C, Dai KZ, Madssen TS, Vaage JT, Gustavsen A, Yang W, Nissen-Meyer LSH, Douvlataniotis K, Laos M, Nielsen MM, Thiede B, Søraas A, Lund-Johansen F, Rustad EH, Olweus J (2023)
Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants
Cell Rep, 42 (1), 111995
DOI 10.1016/j.celrep.2023.111995, PubMed 36656713

Mirlashari MR, Vetlesen A, Nissen-Meyer LSH, Hetland G (2023)
Effects of storage on quality and function of acid-treated platelets with reduced HLA Class I surface expression
Transfus Med, 33 (4), 329-336
DOI 10.1111/tme.12983, PubMed 37356816

Nissen-Meyer LSH (2023)
Efforts to recruit and enhance blood donor return probability: A point of view from Oslo, Norway
Transfus Apher Sci, 62 (4), 103760
DOI 10.1016/j.transci.2023.103760, PubMed 37453908

Nissen-Meyer LSH, Macpherson ME, Skeie LG, Hvalryg M, Llohn AH, Steinsvåg TT, Fenstad MH, Tveita A, Kristoffersen EK, Sundic T, Lund-Johansen F, Vaage JT, Flesland Ø, Dyrhol-Riise AM, Holter JC, Hervig TA, Fevang B (2023)
COVID-19 patients treated with convalescent plasma
Tidsskr Nor Laegeforen, 143 (11)
DOI 10.4045/tidsskr.22.0577, PubMed 37589359

Nissen-Meyer LSH, Steinsvåg TT, Fenstad MH, Sørvoll IH, Hvalryg M, Titze TL, Magnussen K, Kristoffersen G, Johnsen KMN, Llohn AH, Hermundstad B, Høiback LS, Haugen M, Kristoffersen EK, Boulland LML, Kran AB, Lund-Johansen F, Vaage JT, Flesland Ø, Hervig TA (2023)
Convalescent plasma from Norwegian blood donors to treat COVID-19
Tidsskr Nor Laegeforen, 143 (11)
DOI 10.4045/tidsskr.22.0180, PubMed 37589362

Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2023)
Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
NPJ Vaccines, 8 (1), 4
DOI 10.1038/s41541-023-00600-6, PubMed 36697432

Publications 2022

Hervig TA, Flesland Ø, Nissen-Meyer LSH (2022)
COVID-19 convalescent plasma: current status, lessons from the past and future perspectives
Transfus Apher Sci, 61 (4), 103487
DOI 10.1016/j.transci.2022.103487, PubMed 35778352

Hetland G, Fagerhol MK, Dimova-Svetoslavova VP, Mirlashari MR, Nguyen NT, Lind A, Kolset SO, Søraas AVL, Nissen-Meyer LSH (2022)
Inflammatory markers calprotectin, NETs, syndecan-1 and neopterin in COVID-19 convalescent blood donors
Scand J Clin Lab Invest, 82 (6), 481-485
DOI 10.1080/00365513.2022.2123387, PubMed 36151851

Hetland G, Fagerhol MK, Wiedmann MKH, Søraas AVL, Mirlashari MR, Nissen-Meyer LSH, Istre MS, Holme PA, Schultz NH (2022)
Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side Effects
Vaccines (Basel), 10 (8)
DOI 10.3390/vaccines10081267, PubMed 36016155

Kared H, Wolf AS, Alirezaylavasani A, Ravussin A, Solum G, Tran TT, Lund-Johansen F, Vaage JT, Nissen-Meyer LS, Nygaard UC, Hungnes O, Robertson AH, Næss LM, Trogstad L, Magnus P, Munthe LA, Mjaaland S (2022)
Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults
Nat Commun, 13 (1), 4165
DOI 10.1038/s41467-022-31888-y, PubMed 35851055

Nissen-Meyer LSH, Czapp E, Naper C, Jensen T, Boulland LML (2022)
Screening for antibodies to HLA class I in apheresis donors following Covid-19 or SARS-CoV-2 vaccination
Transfus Apher Sci, 61 (5), 103567
DOI 10.1016/j.transci.2022.103567, PubMed 36089469

Nissen-Meyer LSH, Ezligini F, Bergerud UE, Holtan A, Akkök ÇA, Danilova E, Hetland G (2022)
[Blood and emergency preparedness]
Tidsskr Nor Laegeforen, 142 (11)
DOI 10.4045/tidsskr.22.0494, PubMed 35997179

Nissen-Meyer LSH, Hervig T, Fevang B, Norheim G, Kran AB, Vaage JT, Flesland Ø (2022)
COVID-19 convalescent plasma from Norwegian blood donors
Tidsskr Nor Laegeforen, 142 (9)
DOI 10.4045/tidsskr.22.0057, PubMed 35699539

Riise J, Meyer S, Blaas I, Chopra A, Tran TT, Delic-Sarac M, Hestdalen ML, Brodin E, Rustad EH, Dai KZ, Vaage JT, Nissen-Meyer LSH, Sund F, Wader KF, Bjornevik AT, Meyer PA, Nygaard GO, König M, Smeland S, Lund-Johansen F, Olweus J, Kolstad A (2022)
Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination
Br J Haematol, 197 (6), 697-708
DOI 10.1111/bjh.18149, PubMed 35254660

Syversen SW, Jyssum I, Tveter AT, Tran TT, Sexton J, Provan SA, Mjaaland S, Warren DJ, Kvien TK, Grødeland G, Nissen-Meyer LSH, Ricanek P, Chopra A, Andersson AM, Kro GB, Jahnsen J, Munthe LA, Haavardsholm EA, Vaage JT, Lund-Johansen F, Jørgensen KK, Goll GL (2022)
Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy
Arthritis Rheumatol, 74 (8), 1321-1332
DOI 10.1002/art.42153, PubMed 35507355

Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2022)
Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
NPJ Vaccines, 7 (1), 174
DOI 10.1038/s41541-022-00586-7, PubMed 36585405

Publications 2021

Al-Riyami AZ, Burnouf T, Yazer M, Triulzi D, Kumaş LT, Sağdur L, Pelit NB, Bazin R, Hindawi SI, Badawi MA, Patidar GK, Pandey HC, Chaurasia R, Fachini RM, Scuracchio P, Wendel S, Ang AL, Ong KH, Young P, Ihalainen J, Vierikko A, Qiu Y, Yang R, Xu H, Rahimi-Levene N et al. (2021)
International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary
Vox Sang, 116 (10), 1117-1135
DOI 10.1111/vox.13113, PubMed 34013968

Al-Riyami AZ, Burnouf T, Yazer M, Triulzi D, Kumaş LT, Sağdur L, Pelit NB, Bazin R, Hindawi SI, Badawi MA, Patidar GK, Pandey HC, Chaurasia R, Fachini RM, Scuracchio P, Wendel S, Ang AL, Ong KH, Young P, Ihalainen J, Vierikko A, Qiu Y, Yang R, Xu H, Rahimi-Levene N et al. (2021)
International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Responses
Vox Sang, 116 (10), e71-e120
DOI 10.1111/vox.13114, PubMed 34013981

Goldman M, Townsend M, Magnussen K, Lozano M, Nissen-Meyer LSH, Lee CK, Leung JN, Takanashi M, McKay J, Kvist M, Robitaille N, Deschênes J, Di Angelantonio E, McMahon A, Roberts D, Maghsudlu M, Castrén J, Tiberghien P, Woimant G, Morel P, Kamel H, Bravo M, Shinar E, Gendelman V, Raz H et al. (2021)
International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Responses
Vox Sang, 116 (3), e1-e24
DOI 10.1111/vox.13038, PubMed 33754360

Holm S, Kared H, Michelsen AE, Kong XY, Dahl TB, Schultz NH, Nyman TA, Fladeby C, Seljeflot I, Ueland T, Stensland M, Mjaaland S, Goll GL, Nissen-Meyer LS, Aukrust P, Skagen K, Gregersen I, Skjelland M, Holme PA, Munthe LA, Halvorsen B (2021)
Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia
Eur Heart J, 42 (39), 4064-4072
DOI 10.1093/eurheartj/ehab506, PubMed 34405870

Hvalryg M, Nissen-Meyer LSH (2021)
Sero-prevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Norway, winter/spring 2021
Transfus Apher Sci, 60 (5), 103256
DOI 10.1016/j.transci.2021.103256, PubMed 34420881

Mirlashari MR, Vetlesen A, Nissen-Meyer LSH, Naper C, Tjønnfjord GE, Njerve IU, Ezligini F, Landmark BF, Meinke S, Sandgren P, Höglund P, Hetland G (2021)
HLA class I depletion by citric acid, and irradiation of apheresis platelets for transfusion of refractory patients
Transfusion, 61 (4), 1222-1234
DOI 10.1111/trf.16282, PubMed 33580979

Mirlashari MR, Vetlesen A, Nissen-Meyer LSH, Stensland ME, Singh SK, Nyman TA, Hetland G (2021)
Proteomic study of apheresis platelets made HLA class I deficient for transfusion of refractory patients
Proteomics Clin Appl, 15 (6), e2100022
DOI 10.1002/prca.202100022, PubMed 34510746

Nissen-Meyer LSH, Brantsæter AB (2021)
The story of an extraordinary year: Challenges and opportunities in responding to Covid-19
Transfus Apher Sci, 60 (2), 103092
DOI 10.1016/j.transci.2021.103092, PubMed 33612447

Pandey S, Gorlin JB, Townsend M, Van Buren N, Leung JNS, Lee CK, van den Hurk K, Casamitjana N, Valles R, Alonso E, Miller YM, Richard P, Woimant G, Tiberghien P, Zhiburt E, Butler-Foster T, Goldman M, Nissen-Meyer LSH, Espinosa A, Kamel H, Bravo M, Filho LA, Pecego M, Germain M, Rabusseau I et al. (2021)
International Forum on Gender Identification and Blood Collection: Summary
Vox Sang, 117 (3), 447-456
DOI 10.1111/vox.13192, PubMed 34545579

Pandey S, Gorlin JB, Townsend M, Van Buren N, Leung JNS, Lee CK, van den Hurk K, Casamitjana N, Valles R, Alonso E, Miller YM, Richard P, Woimant G, Tiberghien P, Zhiburt E, Butler-Foster T, Goldman M, Nissen-Meyer LSH, Espinosa A, Kamel H, Bravo M, Filho LA, Pecego M, Germain M, Rabusseau I et al. (2021)
International Forum on Gender Identification and Blood Collection: Responses
Vox Sang, 117 (3), E21-E43
DOI 10.1111/vox.13193, PubMed 34545590

Publications 2020

Fagerhol MK, Johnson E, Tangen JM, Hollan I, Mirlashari MR, Nissen-Meyer LSH, Hetland G (2020)
NETs analysed by novel calprotectin-based assays in blood donors and patients with multiple myeloma or rheumatoid arthritis: A pilot study
Scand J Immunol, 91 (5), e12870
DOI 10.1111/sji.12870, PubMed 32034957

Goldman M, Townsend M, Magnussen K, Lozano M, Nissen-Meyer LS, Lee CK, Leung JN, Takanashi M, McKay J, Kvist M, Robitaille N, Deschênes J, Di Angelantonio E, McMahon A, Roberts D, Maghsudlu M, Castrén J, Tiberghien P, Woimant G, Morel P, Kamel H, Bravo M, Shinhar E, Gendelman V, Raz H et al. (2020)
Vox Sanguinis International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Summary
Vox Sang, 116 (3), 351-359
DOI 10.1111/vox.13037, PubMed 33245787

Hetland G, Tangen JM, Mahmood F, Mirlashari MR, Nissen-Meyer LSH, Nentwich I, Therkelsen SP, Tjønnfjord GE, Johnson E (2020)
Antitumor, Anti-Inflammatory and Antiallergic Effects of Agaricus blazei Mushroom Extract and the Related Medicinal Basidiomycetes Mushrooms, Hericium erinaceus and Grifola frondosa: A Review of Preclinical and Clinical Studies
Nutrients, 12 (5)
DOI 10.3390/nu12051339, PubMed 32397163

Publications 2019

Johnson E, Therkelsen SP, Nentwich I, Nissen-Meyer LSH, Hetland G (2019)
IgE-sensitization to food and inhalant allergens in IBD patients compared with normal blood donors at Oslo University Hospital, Norway
Scand J Gastroenterol, 54 (9), 1107-1110
DOI 10.1080/00365521.2019.1663445, PubMed 31524013

Mahmood F, Hetland G, Nentwich I, Mirlashari MR, Ghiasvand R, Nissen-Meyer LSH (2019)
Agaricus blazei-Based Mushroom Extract Supplementation to Birch Allergic Blood Donors: A Randomized Clinical Trial
Nutrients, 11 (10)
DOI 10.3390/nu11102339, PubMed 31581605

Post JI, Leergaard TB, Ratz V, Walaas SI, von Hörsten S, Nissen-Meyer LSH (2019)
Differential Levels and Phosphorylation of Type 1 Inositol 1,4,5-Trisphosphate Receptor in Four Different Murine Models of Huntington Disease
J Huntingtons Dis, 8 (3), 271-289
DOI 10.3233/JHD-180301, PubMed 31256144

Publications 2018

Nissen-Meyer LSH, Seghatchian J (2018)
Donor health assessment - When is blood donation safe?
Transfus Apher Sci, 58 (1), 113-116
DOI 10.1016/j.transci.2018.12.016, PubMed 30630765

Publications 2017

Nissen-Meyer LSH, Chaudhry FA (2017)
Corrigendum: Protein Kinase C Phosphorylates the System N Glutamine Transporter SN1 (Slc38a3) and Regulates Its Membrane Trafficking and Degradation
Front Endocrinol (Lausanne), 8, 190
DOI 10.3389/fendo.2017.00190, PubMed 28835749

Publications 2015

Nissen-Meyer LS, Tjønnfjord GE, Golebiowska E, Kjeldsen-Kragh J, Akkök ÇA (2015)
Paroxysmal nocturnal haemoglobinuria at Oslo University Hospital 2000-2010
Tidsskr Nor Laegeforen, 135 (11), 1039-43
DOI 10.4045/tidsskr.14.0444, PubMed 26080779

Publications 2013

Nissen-Meyer LS, Chaudhry FA (2013)
Protein Kinase C Phosphorylates the System N Glutamine Transporter SN1 (Slc38a3) and Regulates Its Membrane Trafficking and Degradation
Front Endocrinol (Lausanne), 4, 138
DOI 10.3389/fendo.2013.00138, PubMed 24106489

Publications 2011

Nissen-Meyer LS, Popescu MC, Hamdani el H, Chaudhry FA (2011)
Protein kinase C-mediated phosphorylation of a single serine residue on the rat glial glutamine transporter SN1 governs its membrane trafficking
J Neurosci, 31 (17), 6565-75
DOI 10.1523/JNEUROSCI.3694-10.2011, PubMed 21525297

Publications 2008

Kvamme E, Nissen-Meyer LS, Roberg BA, Torgner IA (2008)
Novel form of phosphate activated glutaminase in cultured astrocytes and human neuroblastoma cells, PAG in brain pathology and localization in the mitochondria
Neurochem Res, 33 (7), 1341-5
DOI 10.1007/s11064-008-9589-9, PubMed 18274897

Nissen-Meyer LS, Svalheim S, Taubøll E, Gjerstad L, Reinholt FP, Jemtland R (2008)
How can antiepileptic drugs affect bone mass, structure and metabolism? Lessons from animal studies
Seizure, 17 (2), 187-91
DOI 10.1016/j.seizure.2007.11.024, PubMed 18180177

Pedersen ME, Fortunati D, Nielsen M, Brorson SH, Lekva T, Nissen-Meyer LS, Gautvik VT, Shahdadfar A, Gautvik KM, Jemtland R (2008)
Calmodulin-dependent kinase 1beta is expressed in the epiphyseal growth plate and regulates proliferation of mouse calvarial osteoblasts in vitro
Bone, 43 (4), 700-7
DOI 10.1016/j.bone.2008.06.006, PubMed 18620088

Publications 2007

Nissen-Meyer LS, Jemtland R, Gautvik VT, Pedersen ME, Paro R, Fortunati D, Pierroz DD, Stadelmann VA, Reppe S, Reinholt FP, Del Fattore A, Rucci N, Teti A, Ferrari S, Gautvik KM (2007)
Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice
J Cell Sci, 120 (Pt 16), 2785-95
DOI 10.1242/jcs.003855, PubMed 17652162

Nissen-Meyer LS, Svalheim S, Taubøll E, Reppe S, Lekva T, Solberg LB, Melhus G, Reinholt FP, Gjerstad L, Jemtland R (2007)
Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism
Epilepsia, 48 (10), 1850-60
DOI 10.1111/j.1528-1167.2007.01176.x, PubMed 17634065

Reppe S, Stilgren L, Abrahamsen B, Olstad OK, Cero F, Brixen K, Nissen-Meyer LS, Gautvik KM (2007)
Abnormal muscle and hematopoietic gene expression may be important for clinical morbidity in primary hyperparathyroidism
Am J Physiol Endocrinol Metab, 292 (5), E1465-73
DOI 10.1152/ajpendo.00487.2006, PubMed 17227961

Publications 2006

Reppe S, Stilgren L, Olstad OK, Brixen K, Nissen-Meyer LS, Gautvik KM, Abrahamsen B (2006)
Gene expression profiles give insight into the molecular pathology of bone in primary hyperparathyroidism
Bone, 39 (1), 189-98
DOI 10.1016/j.bone.2005.12.020, PubMed 16516570

Page visits: 3932